China Resources: A chain pharmacy that can't be sent out

From the lofty "million shop plan" to today's abandonment of the fear, 8.5 time, 39 of the chain of medicine experience what? Wen |cbn reporter Li Na two degrees sold not fruit, 39 medicine chain once again put on the wedding dress.　　This time, Dongjiahua run group to this once proposed to create "China chain Pharmacy first brand" Business price is only 2 yuan, the price is not lenient.　　Earlier, SASAC has just announced that the pharmaceutical products production and trade, related technology research and development and services into the main areas of China Resources Group, China Resources Group chairman Lin immediately said that China Resources pharmaceutical business will be listed in Hong Kong before 2012, before this need to clarify 39 business assets.　　November 4, 39 Pharmaceutical Co., Ltd. (hereinafter referred to as "39 medicine") and Shenzhen 39 Pharmaceutical Trading Co., Ltd. issued a notice will be held in Shenzhen 39 pharmaceutical Chain Co., Ltd. (hereinafter referred to as "39 chain") 93.6% of the shares and 6.4% of the shares of the transfer, listing price of 1 yuan.　　For China Resources, stripping the business from the pharmaceutical sector is almost a decision that can be made without thinking about it. China Resources Pharmaceutical Group for Huayuan Group, Sanjiu Group Pharmaceutical Resources reorganization set up, the annual turnover of more than 27 billion yuan. 2009, 39 pharmaceutical industry in the first three quarters to achieve income of 3.392 billion yuan, the year-on-year growth of 19%, the pharmaceutical business growth of more than 20%, of which the cold spirit series and 39 stomach-Thai income growth of 35%. By contrast, the 39 chain business looks pathetic. In addition to poor performance, the latter has nearly 120 million trillion yuan in debt, even in 2008, Walkson (Beijing) International Asset Assessment Limited has a negative value on its net worth.　　And the sale can raise 39 pharmaceutical industry main business income proportion and the wool interest rate level, simultaneously, the recovery 87.05 million yuan accounts receivable. But the problem is that even if the price of the 39 chain falls again, no one is willing to take over the "big loss specimen". As soon as the takeover, in addition to bear the corresponding huge debts, but also faced with high management costs and strong competitors (China-union, Neptune stars, Xinwanzer, etc.).　　In addition, the year 39 chain layout scattered throughout the country, did not form a core area of sales also make the buyers worry about the profits can not be guaranteed.　　Eight years ago, such a situation was completely unthinkable. 39 Pharmaceutical chain was established in May 2001, to the end of July 2002, 39 chain pharmacies have reached more than 600, distributed in 15 provinces in the country 23 cities. At that time as Sanjiu Enterprise Group Secretary and president of the Siang put forward the hit "million" concept, and formulated a "McDonald's plan" and "Wal-Mart strategy." One of the "Wal-Mart Strategy" is to be in 3 years time, with raised 1.3 billion yuan quickly occupy the national pharmaceutical retail not less than 5% of the market share, and opened 10,000 chain pharmacies. Later in a short span of one year, the size of the 39 pharmaceutical chain reached more than 1000. However, due to the high cost of open shop, and standardized management and operating cost control is weak, 39 medicine chain debt, millionThe dream of the family chain was shattered after five years of Zhao in jail. August 11, 2006, Zhejiang Yao Pharmaceutical Group Co., Ltd. to deal with the price of 17.1 million yuan to buy 39 medicine chain 93.6% of the shares, but due to failure within the stipulated period with 39 medical AG on equity transactions signed agreement, resulting in the first stock auction failed to deal.　　The second auction is even more trifling-no medical assets of the Beihai economic and Trade limited liability company to 4 million of the amount of the 39 chain of more than 1000 pharmacies, and finally because the industry recession and other reasons without the following. In the second half of 2008 years, the OTC leading enterprises have left hundreds of stores, positioning has become China Resources Medicine's focus on the core brand of Chinese medicine platform. But for China Resources Pharmaceutical Group, it is more important to do a good job in the pharmaceutical field of specialization, 39 chain in the reorganization began to enter the company's business stripping channel.　　For the large state-owned enterprise, which is eager to "concentrate", the 39 chain is no different from the "39 packaging and printing business" and "real estate business". From the original oath China's first heroic to send also can not send out embarrassment, 39 chain 8.5 time experience is a game or a dream?